Progress and prospects of gene therapy in ophthalmology from 2000 to 2022: A bibliometric analysis

Bingyan Li; Wei Tan; Zicong Wang; Haixiang Zhou; Jingling Zou; Yun Li; Shigeo Yoshida; Yedi Zhou

doi:10.1016/j.heliyon.2023.e18228

Progress and prospects of gene therapy in ophthalmology from 2000 to 2022: A bibliometric analysis

Heliyon. 2023 Jul 14;9(7):e18228. doi: 10.1016/j.heliyon.2023.e18228. eCollection 2023 Jul.

Authors

Bingyan Li^{1

2

3}, Wei Tan^{1

2

3}, Zicong Wang^{1

2

3}, Haixiang Zhou^{1

2

3}, Jingling Zou^{1

2

3}, Yun Li^{1

2

3}, Shigeo Yoshida⁴, Yedi Zhou^{1

2

3}

Affiliations

¹ Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
² Hunan Clinical Research Center of Ophthalmic Disease, Changsha, Hunan, 410011, China.
³ National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
⁴ Department of Ophthalmology, Kurume University School of Medicine, Kurume, Fukuoka, 830-0011, Japan.

Abstract

Background: Gene therapy is a treatment approach at the genetic level, which brings great advances in many diseases and develops rapidly in recent years. Currently, its mechanism of action is mainly through the replacement of missing or defective genes, or the reduction of harmful gene products. However, the application of gene therapy in ophthalmology remains limited.

Methods: A total of 1143 articles and reviews published in the field of ocular gene therapies were found in the Web of Science Core Collection database and used for the bibliometric analysis. CiteSpace was mainly applied to the network analysis of countries, institutions, keywords, and dual-map overlay of journals. The visual analysis of authors, journals, and references was used by VOSviewer. The geographical distribution of publications was conducted by R language.

Results: The annual publications are increasing in general. Currently, the USA and the UK are two main sources of publications in this field. Switzerland, Denmark, and Finland are the top 3 countries that establish the most cooperation and exchanges with other countries or regions. The most cited and co-cited journal in this field is Investigative Ophthalmology & Visual Science. Gene therapy studies for eye diseases are mainly focused on retinal dysfunctions by the analysis of references, keywords, and counting of original research, including Leber's congenital amaurosis and retinitis pigmentosa.

Conclusion: This study used bibliometrics to analyze overall characteristics and put forward prospects for the future in the field of gene therapy in ophthalmology. Ocular diseases, especially hereditary retinal diseases, will be the major focus of gene therapy in the future.

Keywords: Bibliometric analysis; CiteSpace; Gene therapy; Ophthalmology; VOSviewer.